3M Pediatric Submission for QVAR
Selected Abstract
3M Pediatric Submission for QVAR(TM) (beclomethasone dipropionate HFA) Inhalation Aerosol May Pave the Way for Kids to Breathe Easier.
ST. PAUL, Minn., July 10 /PRNewswire/ -- 3M Pharmaceuticals announced today that it has submitted a supplement to the New Drug Application (NDA) to the U.S. Food and Drug Administration (FDA) seeking approval for use of QVAR (beclomethasone diproprionate HFA) (BDP) inhalation aerosol in children ... July 10, 2001; PR Newswire
Read the full article with a free-trial membership at HighBeam Research
Related Articles 1.
3M Pediatric Submission for QVAR(TM) (beclomethasone dipropionate HFA) Inhalation Aerosol May Pave the Way for Kids to Breathe Easier.
|
